1. ACOG Committee on Genetics. ACOG committee opinion (2004). Prenatal and precon-ceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol. 104: 425-428.
2. Akli S, Guidotti JE, Vigne E, Perricaudet M, Sandhoff K, Kahn A, Poenaru L (1996). Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adeno-viral vector-mediated gene transfer. Gene Ther. 3:769-774.
3. Alkan A, Kutlu R, Yakinci C, Sigirci A, Aslan M, Sarac K (2003). Infantile Sandhoff's disease: multivoxel magnetic resonance spectroscopy findings. J Child Neurol. 8:425-428.
4. Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F (1977). Genetic variants of Tay-Sachs disease and Sandhoff's disease in French-Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population. In: Kaback MM, Rimoin DL, O’Brien JS (Eds.), Tay-Sachs Disease: Screening and Prevention. Alan R. Liss, New York, pp. 161-168.
5. Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, Platt FM (2004). Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis. 16:506-15.